- (prandial
insulins) and long
action (basal
insulins). The
first biosynthetic insulin analog was
developed for
clinical use at
mealtime (prandial
insulin), Humalog...
-
Lantus (
insulin glargine), a long-acting
insulin analog. The
American Diabetes ****ociation said in 2003 that,
unlike some
other longer-acting
insulins, glargine...
-
animal insulins made by Novo
Nordisk were
replaced by synthetic,
recombinant "human"
insulin.[medical
citation needed]
Synthetic "human"
insulin is also...
- to
intermediate acting insulins in the 1980s,
using NPH
formulations of porcine/bovine
insulins.
Basal (long-acting)
insulin analogs were subsequently...
- short-acting
insulins (peak 2–4 hours) are:
Regular insulin (Humulin R,
Novolin R)
Prompt insulin zinc (Semilente)
Examples of intermediate-acting
insulins (peak...
- long-acting
insulins such as
insulin glargine and
insulin detemir),
making it a once-daily
basal insulin, that is one that
provides a base
insulin level, as...
- of
insulin over another" and "[modern,
highly purified]
animal insulins remain a
perfectly acceptable alternative."
Since January 2006, all
insulins distributed...
-
Insulin aspart, sold
under the
brand name NovoLog,
among others, is a
modified type of
medical insulin used to
treat type 1 and type 2 diabetes. It is...
-
developed device designed with this
technology in mind.
Ultrafast insulins.
These insulins are
absorbed more
quickly than the
currently available Humalog...
-
Insulin lispro, sold
under the
brand name
Humalog among others, is a
modified type of
medical insulin used to
treat type 1 and type 2 diabetes. It is...
